Serum amyloid A activation of human coronary artery endothelial cells exhibits a neutrophil promoting molecular profile

Microvascular Research

Volumn 90, Issue , 2013, Pages 55-63

  Lakota, Katja ^a   Mrak Poljsak, Katjusa ^a   Bozic, Borut ^a,b   Tomsic, Matija ^a   Sodin Semrl, Snezna ^a,c  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c UNIVERSITY OF PRIMORSKA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN P105; SCAVENGER RECEPTOR BI; SERUM AMYLOID A; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ENDOTHELIAL CELL; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; MONOCYTE; NEUTROPHIL; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

CELL ADHESION MOLECULES; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIAL CELLS; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHOSPHORYLATION; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; SERUM AMYLOID A PROTEIN; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84888431170     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.07.011     Document Type: Article

References (42)

1. Artl A., et al. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages. Arterioscler. Thromb. Vasc. Biol. 2000, 20:763-772.
2. Baetta R., Corsini A. Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives. Atherosclerosis 2010, 210:1-13.
3. Banerjee A., et al. Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:3274-3279.
4. Bulut Y., et al. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol. 2001, 167:987-994.
5. Chen E.S., et al. Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am. J. Respir. Crit. Care Med. 2010, 181:360-373.
6. Cheng N., et al. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J. Immunol. 2008, 181:22-26.
7. Chiba T., et al. Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1326-1332.
8. Dong Z., et al. Serum amyloid a directly accelerates the progression of atherosclerosis in apolipoprotein e-deficient mice. Mol. Med. 2011, 17:1357-1364.
9. Dunzendorfer S., et al. Flow-dependent regulation of endothelial Toll-like receptor 2 expression through inhibition of SP1 activity. Circ. Res. 2004, 95:684-691.
10. El Kebir D., et al. Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J. Immunol. 2007, 179:616-622.
11. Erridge C., et al. Non-enterobacterial endotoxins stimulate human coronary artery but not venous endothelial cell activation via Toll-like receptor 2. Cardiovasc. Res. 2007, 73:181-189.
12. Faure E., et al. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J. Immunol. 2001, 166:2018-2024.
13. Gantke T., et al. IkappaB kinase regulation of the TPL-2/ERK MAPK pathway. Immunol. Rev. 2012, 246:168-182.
14. He R.L., et al. Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. Blood 2009, 113:429-437.
15. Hirase T., Node K. Endothelial dysfunction as a cellular mechanism for vascular failure. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:H499-H505.
16. Hosokawa T., et al. Neutrophil infiltration and oxidant-production in human atherosclerotic carotid plaques. Histol. Histopathol. 2011, 26:1-11.
17. Johnson B.D., et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004, 109:726-732.
18. Katayama T., et al. Prognostic value of serum amyloid A protein in patients with acute myocardial infarction. Circ. J. 2005, 69:1186-1191.
19. King V.L., et al. Serum amyloid A in atherosclerosis. Curr. Opin. Lipidol. 2011, 22:302-307.
20. Kisilevsky R., Manley P.N. Acute-phase serum amyloid A: perspectives on its physiological and pathological roles. Amyloid 2012, 19:5-14.
21. Lakota K., et al. Serum amyloid A activation of inflammatory and adhesion molecules in human coronary artery and umbilical vein endothelial cells. Eur.J. Inflamm. 2007, 5:73-81.
22. Lakota K., et al. Acute Phase Proteins in Prototype Rheumatic Inflammatory Diseases 2011.
23. Li Y., et al. Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R1670-R1680.
24. Madan M., Amar S. Toll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findings. PLoS One 2008, 3:e3204.
25. Malle E., De Beer F.C. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur. J. Clin. Invest. 1996, 26:427-435.
26. Meek R.L., et al. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:3186-3190.
27. Morrow D.A., et al. Serum amyloid A predicts early mortality in acute coronary syndromes: a TIMI 11A substudy. J. Am. Coll. Cardiol. 2000, 35:358-362.
28. Mullan R.H., et al. Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway. Arthritis Rheum. 2006, 54:105-114.
29. Ridker P.M., et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 2000, 342:836-843.
30. Sandri S., et al. Is serum amyloid A an endogenous TLR4 agonist?. J. Leukoc. Biol. 2008, 83:1174-1180.
31. Shin H.S., et al. Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo. J. Immunol. 2011, 186:1119-1130.
32. Song C., et al. Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. Atherosclerosis 2009, 207:374-383.
33. Tobias P.S., Curtiss L.K. Toll-like receptors in atherosclerosis. Biochem. Soc. Trans. 2007, 35:1453-1455.
34. Wang X., et al. Serum amyloid A induces endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H2399-H2408.
35. Weber C., Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 2011, 17:1410-1422.
36. Wilhelmsen K., et al. Activation of endothelial TLR2 by bacterial lipoprotein upregulates proteins specific for the neutrophil response. Innate Immun. 2011, 18:602-616.
37. Wilhelmsen K., et al. ERK5 promotes, whereas MEK1 differentially regulates, the Toll-like Receptor 2-dependent activation of human endothelial cells and monocytes. J. Biol. Chem. 2012, 287:26478-26494.
38. Wilson P.G., et al. Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner. Am. J. Pathol. 2008, 173:1902-1910.
39. Xiong J., et al. Expression and significance of toll-like receptor 2,4 of peripheral blood mononuclear cells in acute abdomen patients associated with systemic inflammatory response syndrome. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2006, 26:570-572.
40. Yang H.T., et al. Coordinate regulation of TPL-2 and NF-kappaB signaling in macrophages by NF-kappaB1 p105. Mol. Cell Biol. 2012, 32:3438-3451.
41. Zernecke A., Weber C. Chemokines in the vascular inflammatory response of atherosclerosis. Cardiovasc. Res. 2010, 86:192-201.
42. Zhao Y., et al. Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1645-1650.